文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

在机械通气的急诊科患者中实施目标镇静的可行性:ED-SED 试点试验

The Feasibility of Implementing Targeted SEDation in Mechanically Ventilated Emergency Department Patients: The ED-SED Pilot Trial.
PubMed 文献 · Crit Care Med · 2022-04-11
一句话结论多中心前后对照试点试验显示,针对急诊科机械通气患者的教育干预可降低深镇静比例(60.2% 降至 38.8%),且未出现令人担忧的不良事件趋势。

该研究为务实性、多中心(n=3)前瞻性前后对照试点与可行性试验,纳入连续成人急诊科机械通气患者,干预为以可靠记录急诊镇静深度、减少深镇静患者比例为目标的教育举措。深镇静定义为 Richmond 躁动-镇静评分 -3 至 -5 或 Sedation-Agitation 评分 1-3。干预组深镇静比例由 60.2% 降至 38.8%(p<0.01),干预组死亡率 10.0%、干预前组 20.4%(p<0.01),干预组无呼吸机天数 [22.0(9.0)vs 19.9(10.6)] 与无 ICU 天数 [20.8(8.7)vs 18.1(10.4)] 均更多(p 均<0.05)。作者认为该试点试验证实了以急诊科为靶点改善镇静实践、减少深镇静的可行性,并支持开展足够把握度的临床试验。

要点

  • 多中心(n=3)前瞻性前后对照试点试验纳入连续成人急诊科机械通气患者 415 例(筛查 1356 例),干预为针对急诊镇静深度记录与减少深镇静的教育举措。
  • 深镇静(Richmond 躁动-镇静评分 -3 至 -5 或 Sedation-Agitation 评分 1-3)比例由干预前 60.2% 降至干预组 38.8%(p<0.01)。
  • 干预组死亡率 10.0% vs 干预前组 20.4%(p<0.01);干预组无呼吸机天数 22.0(9.0)vs 19.9(10.6)、无 ICU 天数 20.8(8.7)vs 18.1(10.4),p 均<0.05。
  • 不良事件(意外拔管、装置移除、清醒瘫痪)无令人担忧的趋势。
  • 作者认为该试点试验证实了以急诊科为靶点改善镇静实践、减少深镇静的可行性,并支持开展足够把握度的临床试验。

适用人群与场景

  • 连续成人急诊科机械通气患者;研究在 3 个医疗中心的急诊科与 ICU 进行。

诊断标准与关键阈值

  • 深镇静定义为 Richmond 躁动-镇静评分 -3 至 -5 或 Sedation-Agitation 评分 1-3。

研究设计与关键结果

  • 研究设计为务实性、多中心(n=3)前瞻性前后对照试点与可行性试验,在 3 个医疗中心的急诊科与 ICU 进行,筛查 1356 例,最终人群 415 例。
  • 干预为教育举措,目标为可靠记录急诊镇静深度并减少深镇静患者比例(主要结局);记录急诊及入 ICU 后前 48 小时镇静相关数据。
  • 干预组实现更浅的急诊镇静,深镇静患者比例由 60.2% 降至 38.8%(p<0.01)。
  • 不良事件(意外拔管、装置移除、清醒瘫痪)无令人担忧的趋势。
  • 死亡率干预组 10.0% vs 干预前组 20.4%(p<0.01)。
  • 与干预前相比,干预组无呼吸机天数更多 [22.0(9.0)vs 19.9(10.6)],无 ICU 天数更多 [20.8(8.7)vs 18.1(10.4)],p 均<0.05。

证据类型、等级与局限

  • 证据类型:务实性、多中心(n=3)前瞻性前后对照试点与可行性试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为该试点试验证实了以急诊科为靶点改善镇静实践、减少深镇静的可行性,并支持开展足够把握度的临床试验以改善临床结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Deep sedation in the emergency department (ED) is common, increases deep sedation in the ICU, and is negatively associated with outcome. Limiting ED deep sedation may, therefore, be a high-yield intervention to improve outcome. However, the feasibility of conducting an adequately powered ED-based clinical sedation trial is unknown. Our objectives were to assess trial feasibility in terms of: 1) recruitment, 2) protocol implementation and practice change, and 3) safety. Patient-centered clinical outcomes were assessed to better plan for a future large-scale clinical trial.

DESIGN: Pragmatic, multicenter ( n = 3), prospective before-after pilot and feasibility trial.

SETTING: The ED and ICUs at three medical centers.

PATIENTS: Consecutive, adult mechanically ventilation ED patients.

INTERVENTIONS: An educational initiative aimed at reliable ED sedation depth documentation and reducing the proportion of deeply sedated patients (primary outcome).

MEASUREMENTS AND MAIN RESULTS: Sedation-related data in the ED and the first 48 ICU hours were recorded. Deep sedation was defined as a Richmond Agitation-Sedation Scale of -3 to -5 or a Sedation-Agitation Scale of 1-3. One thousand three hundred fifty-six patients were screened; 415 comprised the final population. Lighter ED sedation was achieved in the intervention group, and the proportion of deeply sedated patients was reduced from 60.2% to 38.8% ( p < 0.01). There were no concerning trends in adverse events (i.e., inadvertent extubation, device removal, and awareness with paralysis). Mortality was 10.0% in the intervention group and 20.4% in the preintervention group ( p < 0.01). Compared with preintervention, the intervention group experienced more ventilator-free days [22.0 (9.0) vs 19.9 (10.6)] and ICU-free days [20.8 (8.7) vs 18.1 (10.4)], p < 0.05 for both.

CONCLUSIONS: This pilot trial confirmed the feasibility of targeting the ED in order to improve sedation practices and reduce deep sedation. These findings justify an appropriately powered clinical trial regarding ED-based sedation to improve clinical outcomes.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Fuller BM, Roberts BW, Mohr NM, et al. The Feasibility of Implementing Targeted SEDation in Mechanically Ventilated Emergency Department Patients: The ED-SED Pilot Trial. Crit Care Med. 2022. PMID: 35404327. doi:10.1097/CCM.0000000000005558

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。